0001683168-21-000554.txt : 20210216 0001683168-21-000554.hdr.sgml : 20210216 20210212174226 ACCESSION NUMBER: 0001683168-21-000554 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210216 DATE AS OF CHANGE: 20210212 EFFECTIVENESS DATE: 20210216 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Phio Pharmaceuticals Corp. CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-389435 FILM NUMBER: 21630175 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 FORMER COMPANY: FORMER CONFORMED NAME: RXi Pharmaceuticals Corp DATE OF NAME CHANGE: 20111019 D 1 primary_doc.xml X0708 D LIVE 0001533040 Phio Pharmaceuticals Corp. 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA MASSACHUSETTS 01752 508-767-3861 DELAWARE RXi Pharmaceuticals Corporation RXi Pharmaceuticals Corp Corporation true Gerrit Dispersyn c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Executive Officer Director Caitlin Kontulis c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Executive Officer Geert Cauwenbergh c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director Robert J Bitterman c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director H Paul Dorman c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director Jonathan Freeman c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director Curtis A Lockshin c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director Robert Ferrara c/o Phio Pharmaceuticals Corp 257 Simarano Drive, Suite 101 Marlborough MA MASSACHUSETTS 01752 Director Pharmaceuticals Decline to Disclose 06b false 2021-01-25 false true true true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10002 IL ILLINOIS NV NEVADA NJ NEW JERSEY NY NEW YORK TX TEXAS false 24264137 14001909 10262228 The offering amount includes amounts receivable by the Issuer upon the exercise of warrants to purchase the Issuer's common stock (assuming no cashless exercise). false 14 1190174 0 H.C. Wainwright & Co., LLC, the placement agent for the private placement, received $1,190,174.16 for fees and warrants to purchase up to 342,070 shares of common stock at an exercise price of $3.8375 per share. 0 false Phio Pharmaceuticals Corp. /s/ Gerrit Dispersyn Gerrit Dispersyn President & CEO 2021-02-12